Get the Stockscreener App
9.30
2.31%
-0.22
Anika Therapeutics Inc stock is traded at $9.30, with a volume of 236.40K.
It is down -2.31% in the last 24 hours and down -3.63% over the past month.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
See More
Previous Close:
$9.52
Open:
$9.67
24h Volume:
236.40K
Relative Volume:
2.00
Market Cap:
$134.09M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-1.8343
EPS:
-5.07
Net Cash Flow:
$1.14M
1W Performance:
-7.92%
1M Performance:
-3.63%
6M Performance:
-22.24%
1Y Performance:
-45.87%
1-Day Range:
$9.27
$9.7863
1-Week Range:
$9.27
$10.07
52-Week Range:
$7.8701
$18.37
Anika Therapeutics Inc Stock (ANIK) Company Profile
Name
Anika Therapeutics Inc
Sector
Phone
(781) 457-9000
Address
32 WIGGINS AVENUE, BEDFORD, MA
Compare ANIK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
9.30 | 137.29M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | B. Riley Securities | Buy |
| Nov-01-24 | Reiterated | Barrington Research | Outperform |
| Aug-14-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-07-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-09-22 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-14-22 | Resumed | Stephens | Equal-Weight |
| Mar-09-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-16-21 | Initiated | Stephens | Overweight |
| Jul-16-21 | Initiated | UBS | Neutral |
| Dec-16-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-08-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-21-20 | Upgrade | Sidoti | Neutral → Buy |
| Jan-10-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Nov-05-19 | Initiated | BWS Financial | Sell |
| Sep-24-19 | Reiterated | Barrington Research | Outperform |
| Sep-23-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Strong Buy |
| Feb-22-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Feb-22-19 | Downgrade | Sidoti | Buy → Neutral |
| Jul-27-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jun-20-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-20-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| May-04-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-23-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-24-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Oct-27-17 | Reiterated | Barrington Research | Outperform |
| May-09-16 | Upgrade | Singular Research | BUY - Long-Term → Buy |
| Apr-27-16 | Downgrade | Northland Capital | Outperform → Market Perform |
| Feb-26-16 | Reiterated | Barrington Research | Outperform |
View All
Anika Therapeutics Inc Stock (ANIK) Latest News
How Anika Therapeutics Inc. (AKP) stock reacts to Fed tighteningMarket Volume Report & Smart Money Movement Alerts - newser.com
Can Anika Therapeutics Inc. (AKP) stock deliver consistent EPS growthJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
Will Anika Therapeutics Inc. (AKP) stock hit analyst forecastsQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Will Anika Therapeutics Inc. stock benefit from sector rotationWeekly Investment Report & Fast Gain Stock Tips - newser.com
How Anika Therapeutics Inc. stock responds to policy changesPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
Is Anika Therapeutics Inc. (AKP) stock a buy on weakness - newser.com
How Anika Therapeutics Inc. (AKP) stock reacts to fiscal policies2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
Detecting support and resistance levels for Anika Therapeutics Inc.2025 Retail Activity & AI Driven Price Forecasts - newser.com
How strong is Anika Therapeutics Inc. stock balance sheet2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Is Anika Therapeutics Inc. stock attractive after correctionJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com
Is Anika Therapeutics Inc. stock positioned for long term growthTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Is Anika Therapeutics Inc. stock supported by strong cash flowsEarnings Performance Report & Real-Time Stock Entry Alerts - newser.com
Is Anika Therapeutics Inc. (AKP) stock a buy before new product rolloutIPO Watch & Daily Profit Maximizing Tips - newser.com
Why Anika Therapeutics Inc. (AKP) stock stays resilient2025 Market Outlook & Reliable Breakout Forecasts - newser.com
What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 20252025 Volatility Report & AI Powered Trade Plan Recommendations - newser.com
Will Anika Therapeutics Inc. stock reach all time highs in 20252025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com
Is Anika Therapeutics Inc. (AKP) stock resilient in recession scenariosPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Is Anika Therapeutics Inc. stock undervalued vs historical averages2025 Investor Takeaways & Daily Stock Trend Watchlist - newser.com
Anika Therapeutics Inc Stock (ANIK) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):